Cite
HARVARD Citation
Ru, Y. et al. (2019). Neurofilament light is a treatment‐responsive biomarker in CLN2 disease. Annals of clinical and translational neurology. 6 (12), pp. 2437-2447. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ru, Y. et al. (2019). Neurofilament light is a treatment‐responsive biomarker in CLN2 disease. Annals of clinical and translational neurology. 6 (12), pp. 2437-2447. [Online].